Clinical Trial Update: Irinotecan and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases From Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluated the combination of irinotecan with whole-brain radiation therapy in patients with brain metastases from solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Drugs mentioned

• Irinotecan (Irinotecan)

Snippet

Sponsor: University of California, Davis | Conditions: Brain and Central Nervous System Tumors, Cognitive/Functional Effects | Phase 1, Phase 2 | Status: COMPLETED